Hilde Stevens is Co-director of the I³h Institute and holds the Interfaculty Chair in Health Innovation & Society, supported by the ULB’s Faculty of Medicine and the Solvay Brussels School of Economics and Management (SBS-EM). She coordinates the Interdisciplinary Program in Healthcare Innovation, organized for Master students, PhD students and postdocs from all (Belgian) universities as well as for professionals. Her research focuses on collaborative innovation models, intellectual property (IP) and mechanisms governing access to medicines in the least developed countries (LDCs), particularly the governance and performance of public-private partnerships and their added value to accelerate innovative therapy development.




Google Scholar 

I3h website 


  • As co-director of the I3h Institute, Hilde contributes to the visibility of the Solvay Brussels School of Economics and Management and the Faculty of Medicine, in terms of research and education.
  • Hilde is coordinator the Interdisciplinary Program in Healthcare Innovation. The interfaculty and interuniversity nature of this educational program puts both faculties, as well as the ULB more broadly, at the heart of healthcare innovation, a field in continuous development.
  • She is a member of the Steering Committee of the Advanced Master in Biotech/Medtech Ventures at Solvay Brussels School.
  • She is a supervisor of PhD students.
  • Member of the Commission Programme (CP) de Sciences Biomédicales de la Faculté de Médecine.
  • Hilde has been Founding Member, Academic Coordinator, Treasurer and Vice-chair in EUPATI Belgium (2016-2020), the Belgian Patient Platform, supported by EUPATI (European Patients’ Academy on Therapeutic Innovation). There she laid the foundation for her work on patient-centricity.
  • She is Guest Professor at the KU Leuven.
  • She is Work Package Leader in ADVANCE, a strategic partnership project under Erasmus+: Advanced Therapy Medicinal Products (ATMPs) for young professionals.
  • She is involved in science popularization to young adults: for Frontiers for Young Minds, she wrote for example articles explaining the benefits of vaccination for HPV and Covid-19.
  • Interdisciplinary Program in Healthcare Innovation (BIME-G-5505), for Master students, PhD researchers and postdocs from different faculties from all the Belgian universities, and beyond (universities abroad, professionals)
  • Basics of preclinical and clinical research (BIME-G-5512), Faculty of Medicine
  • Involved in the set-up and coordination of the Advanced Master in Biotech/Medtech Ventures, Solvay Brussels School
  • Mermelstein S, Stevens H. TRIPS to Where? A Narrative Review of the Empirical Literature on Intellectual Property Licensing Models to Promote Global Diffusion of Essential Medicines. Pharmaceutics (2022), 14(1):48. https://doi.org/10.3390/pharmaceutics14010048
  • van Overbeeke E, Michelsen S, Toumi M, Stevens H, Trusheim M, Meslin E, Huys I, Simoens S. Market access of gene therapies across Europe, USA and Canada: challenges, trends and solutions. Drug Discov Today (2020), https://doi. org/10.1016/j.drudis.2020.11.024
  • Stevens H and Huys I. Innovative Approaches to Increase Access to Medicines in Developing Countries. Frontiers in Medicine 2017, 4:218 doi: 10.3389/fmed.2017.00218
  • Stevens H, Van Overwalle G, Van Looy B, Huys I. Intellectual property policies in early-phase research Public-Private Partnerships. Nature Biotechnology 2016, 34(5), 504-10 doi:10.1038/nbt.356
  • Stevens H, Huys I. The role of Intellectual Property in Early-Phase Research Public-Private Partnerships in the Biomedical Sector. The Cambridge Handbook of Public-Private Partnerships, Intellectual Property Governance, and Sustainable Development. Cambridge University Press, September 2018, pp 109-140.
  • Associate Editor at Frontiers’ Regulatory Science section;
  • Awarded a Grant from Brocher Foundation, Geneva for a research stay (in 2013, in 2015 and 2017), and a Symposium (4-7 Nov. 2018);
  • Winner of the KU Leuven PhD Interaction Day (2013);
  • Winner of the KBC Award for best in-company project, and InBev Innovation Award during her Master in General Management at Vlerick Management School.